🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $SFIX and executed a BUY strategy, securing a +31.52% net profit.
UPGRADE TO SEE LIVE SIGNALS
$PCRX
Pacira BioSciences, Inc.
FREE PREVIEW
📅 Next Earnings: Aug 04, 2026 🌙 Close🌐 Website🏛️ NASDAQ📁 Healthcare🏭 Drug Manufacturers – Specialty & Generic
AVG HISTORICAL GAP0.72%
MAX GAP RECORD13.56%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY3.9%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL